首页 › 基金 › GordonMD Global Investments LP › CLDX
GordonMD Global Investments LP 对 CLDX 的持仓历史
CELLDEX THERAPEUTICS INC NEW · 医疗保健
GordonMD Global Investments LP 在 Q3 2026 的 13F 申报中披露持有 CLDX(CELLDEX THERAPEUTICS INC NEW)279,720 股,市值约 US$9.1M,约占其申报组合的 5.45%,在其申报持仓中市值排名第 4 位。 GordonMD Global Investments LP 最近 4 个申报季度中有 4 个季度披露了 CLDX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
GordonMD Global Investments LP 对 CLDX 的持仓演变
GordonMD Global Investments LP 于 Q4 2025 首次披露 CLDX 持仓:170,307 股(约 US$4.6M)。 该持仓在 Q2 2026 达到峰值 279,720 股,市值约 US$10.4M。 在 4 次申报中,GordonMD Global Investments LP 1 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 279,720 股、市值约 US$9.1M。 持仓曾出现大幅变动:Q2 2026 增持约 64% (随后一个季度股价下跌 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 170.31K | $4.63M | 新进 |
| Q1 2026 | 170.31K | $5.40M | 持有 |
| Q2 2026 | 279.72K | $10.41M | 增持 |
| Q3 2026 | 279.72K | $9.07M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CLDX 与 13F 数据
CLDX(CELLDEX THERAPEUTICS INC NEW)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 CLDX,申报仓位最大的包括:Kynam Capital Management, LP (US$164.2M), Deep Track Capital, LP (US$68.9M), EVENTIDE ASSET MANAGEMENT, LLC (US$61.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CLDX 的基金
- Kynam Capital Management, LP 5.07M 股 · $164.19M · Q3 2026
- Deep Track Capital, LP 2.13M 股 · $68.89M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.90M 股 · $61.46M · Q3 2026
- Commodore Capital LP 1.35M 股 · $50.23M · Q2 2026
- Bellevue Group AG 1.20M 股 · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M 股 · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M 股 · $38.14M · Q2 2026
- Eversept Partners, LP 1.17M 股 · $38.07M · Q3 2026
- Affinity Asset Advisors, LLC 1.16M 股 · $37.61M · Q3 2026
- Elmind Capital, LP 990.00K 股 · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K 股 · $32.73M · Q2 2026
- ADAR1 Capital Management, LLC 799.30K 股 · $25.91M · Q3 2026
更多关于 GordonMD Global Investments LP
常见问题
How long has GordonMD Global Investments LP held CLDX?
GordonMD Global Investments LP has disclosed CLDX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in CLDX?
As of Q3 2026, GordonMD Global Investments LP holds 279.72K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $9.07M, representing 5.45% of its reported portfolio and ranking #4.
Has GordonMD Global Investments LP been buying or selling CLDX?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP held unchanged its position in CLDX. The position peaked in Q2 2026 at 279.72K shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, EVENTIDE ASSET MANAGEMENT, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.